In this position, Mr. Dudley will oversee biotech investments, according to an Aug. 17 LinkedIn post from the firm.
Prior to his role at Innovation Endeavors, Mr. Dudley served as chief scientific officer at Tempus, a company focused on data and artificial intelligence in healthcare.
Mr. Dudley also served as an associate professor of genetics and genomic sciences and is founding director of the Institute for Next Generation Healthcare at the New York City-based Icahn School of Medicine at Mount Sinai.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
